Editorial Article
Steve Rees, of AstraZeneca, Discusses Cutting-edge Technologies for Drug Target Validation
Steve Rees, Vice-President of Screening Sciences and Sample Management, Talks to Kerry Parker
Steve Rees, Vice-President of Screening Sciences and Sample Management, Talks to Kerry Parker